26/03/21
Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma.
12/03/21
New study to influence clinical practice globally Changing how pre-term babies' umbilical cords are clamped could improve outcomes and save babies lives, prompting an update of the international guidelines that inform global practice.
01/12/20
The CLARITY 2.0 study looks at the Dimerix lead candidate DMX-200 combined with Angiotensin Receptor Blockers to treat respiratory issues associated with COVID-19. The study will recruit patients at an early stage of respiratory complications, prior to the onset of Acute Respiratory Distress Syndrome (ARDS).
12/11/20
Trained nurse and PhD candidate, Sharon Atkinson-Briggs, has made a huge impact on the prevention and management of diabetes-related eye damage in the Indigenous community in regional Victoria.
12/11/20
ENZAMET scooped the pool at the ACTA Trial of the Year Awards Ceremony winning the 2020 ACTA Trial of the Year Award, the ACTA STInG Award for Excellence in Trial Statistics and the Consumer Involvement Award. A fantastic achievement and the first trial to win all three awards!
22/10/20
We are very pleased to officially welcome Professor Meg Jardine to the CTC to lead the centre into its next phase of growth and development.
14/10/20
On the inaugural World Evidence-Based Healthcare Day, we look back at the successful SNAC (Sentinel Node Biopsy Versus Axillary Clearance) trial to remember the impact it has had on the treatment of women with early breast cancer.
18/09/20
Researchers found cannabis could help reduce nausea and vomiting, two common and debilitating side effects of chemotherapy.
13/08/20
Victoria's number of COVID-19 cases is likely to have peaked late July.
12/08/20
The CTC’s Dr Emma Smith was senior author on a paper that found gout cases have risen up to 20% in Australia in the last 20 years.
10/06/20
The CTC is calling on its research expertise to help bolster responses to COVID-19.
02/06/20
CTC is collaboraing with ANZUP on a world first treatment for prostrate cancer.
01/06/20
A data analytics study from the CTC's Prof Ian Marschner suggests the timing of COVID-19 restrictions in Australia stopped a significant growth in infections.
28/05/20
Following a successful recruitment strategy for the T4DM trial, Karen Bracken shares her lessons learned when recruiting for a trial.
28/04/20
Our Biostatistics Director, Prof Ian Marschner, tells ABC random sampling across geographies is just as important as hot spot testing in determining infection rates.
01/04/20
The vast majority of staff are working from home to ensure clinical trial research can continue.
04/03/20
On World Obesity Day, a new study shows that early education and support for pregnant women and parents could be key to combating rising rates of obesity in Australian kids.
31/01/20
On Australia Day, Director of the CTC, Prof John Simes, received an Order of Australia award (AO) for his service to cancer research and clinical trials
06/12/19
CTC’s Medidata Implementation team and our Health Economics head, A/Prof Rachael Morton, received two coveted awards from the University for 2019.
08/11/19
Australian medical research is at risk of punching below its weight unless more attention is paid to the discipline of biostatistics.
11/10/19
CTC staff shined in the recent Australian Clinical Trials Alliance conference.
24/09/19
The CTC will perform a key role in a newly announced Centre of Research Excellence (CRE) in clinical trials methodology.
09/09/19
The CTC’s Prof Martin Stockler has received the prestigious MOGA Novartis Cancer Achievement Award for his outstanding contribution to medical oncology in Australia.
10/07/19
A new trial being undertaken by the NHMRC Clinical Trials Centre is photographing the back of the eye of those living with diabetes to help them avoid losing their vision and the risks of amputation and heart disease.
14/06/19
The ANZUP-led ENZAMET trial was a stand-out success story at the recent American Society of Clinical Oncology annual conference.
24/05/19
CTC’s partnership with Miracle Babies Foundation - a consumer body representing parents of sick newborns - has received the Australian Clinical Trials Alliance’s inaugural award for consumer engagement.
02/04/19
In a long awaited study on preterm babies, the CTC and its partners have taken a pioneering path to ensure they get enough trial participants and can positively impact babies lives around the word.
11/03/19
Statin therapy is safe and effective in older people over 75 years and reduces major cardiovascular events such as heart attacks and strokes, according to new research by the University of Sydney's Clinical Trials Centre published in The Lancet.
10/01/19
Eleven CTC investigators were awarded new funding from the NHMRC, the ARC, the MRFF, Cure Brain Cancer, and the Danish Diabetes Academy.
13/12/18
CTC leads review of cost-effectiveness for screening and vaccinating migrants for European Union.
13/09/18
Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation to kill tumour cells.
30/07/18
The award was established to celebrate exceptional performance at the University of Sydney.
25/07/18
The Cooperative Trials Group for Neuro-Oncology (COGNO) at the CTC was awarded funding from CanTeen to give adolescent and young adult cancer patients access to the latest in treatment.
25/07/18
In a recent review article, the CTC joins calls for better access to blood glucose meters and test strips for diabetes sufferers.
31/05/18
Congratulations to the CTC's Mbathio Dieng, who won a prestigious University of Sydney Faculty of Medicine Award for her PhD research into managing stress and fear of cancer recurrence in recovering, early-stage melanoma patients.
16/05/18
A life-saving placental transfusion study led by CTC's Professor William Tarnow-Mordi received the Australian Clinical Trials Alliance 'Trial of the Year' Award.
31/07/17
A report authored by ACTA and an Australian Commission says trials return $5.80 for every $1 invested.